265 related articles for article (PubMed ID: 21261684)
21. Non-Hodgkin lymphomas of mice.
Hori M; Xiang S; Qi CF; Chattopadhyay SK; Fredrickson TN; Hartley JW; Kovalchuk AL; Bornkamm GW; Janz S; Copeland NG; Jenkins NA; Ward JM; Morse HC
Blood Cells Mol Dis; 2001; 27(1):217-22. PubMed ID: 11358382
[TBL] [Abstract][Full Text] [Related]
22. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
23. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
24. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
[TBL] [Abstract][Full Text] [Related]
25. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
26. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
[TBL] [Abstract][Full Text] [Related]
27. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
Almasri NM; Iturraspe JA; Braylan RC
Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
[TBL] [Abstract][Full Text] [Related]
28. Fas ligand expression in nodal non-Hodgkin's lymphoma.
Müllauer L; Mosberger I; Chott A
Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
[TBL] [Abstract][Full Text] [Related]
29. Expression of the serpin centerin defines a germinal center phenotype in B-cell lymphomas.
Paterson MA; Hosking PS; Coughlin PB
Am J Clin Pathol; 2008 Jul; 130(1):117-26. PubMed ID: 18550480
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
Dorfman DM; Shahsafaei A
Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
[TBL] [Abstract][Full Text] [Related]
31. Tumor progression in malignant lymphomas.
Warnke RA
Bull Cancer; 1991; 78(2):181-6. PubMed ID: 2036489
[TBL] [Abstract][Full Text] [Related]
32. CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications.
Zhao S; Zhang H; Xing Y; Natkunam Y
Am J Surg Pathol; 2013 Feb; 37(2):250-8. PubMed ID: 23095505
[TBL] [Abstract][Full Text] [Related]
33. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.
Marmey B; Boix C; Barbaroux JB; Dieu-Nosjean MC; Diebold J; Audouin J; Fridman WH; Mueller CG; Molina TJ
Hum Pathol; 2006 Jan; 37(1):68-77. PubMed ID: 16360418
[TBL] [Abstract][Full Text] [Related]
34. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
35. CD80 (B7.1) is expressed on both malignant B cells and nonmalignant stromal cells in non-Hodgkin lymphoma.
Dakappagari N; Ho SN; Gascoyne RD; Ranuio J; Weng AP; Tangri S
Cytometry B Clin Cytom; 2012 Mar; 82(2):112-9. PubMed ID: 22076940
[TBL] [Abstract][Full Text] [Related]
36. The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.
Amé-Thomas P; Tarte K
Semin Cancer Biol; 2014 Feb; 24():23-32. PubMed ID: 23978491
[TBL] [Abstract][Full Text] [Related]
37. Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour.
Mitteldorf C; Bieri M; Wey N; Kerl K; Kamarachev J; Pfaltz M; Kutzner H; Roncador G; Tomasini D; Kempf W
Br J Dermatol; 2013 Dec; 169(6):1212-8. PubMed ID: 23937075
[TBL] [Abstract][Full Text] [Related]
38. T-cell lymphoma: Microenvironment-related biomarkers.
Tse E; Kwong YL
Semin Cancer Biol; 2015 Oct; 34():46-51. PubMed ID: 26057207
[TBL] [Abstract][Full Text] [Related]
39. Shaping of the tumor microenvironment: Stromal cells and vessels.
Blonska M; Agarwal NK; Vega F
Semin Cancer Biol; 2015 Oct; 34():3-13. PubMed ID: 25794825
[TBL] [Abstract][Full Text] [Related]
40. Malignant lymphoma of the conjunctiva.
Kirkegaard MM; Coupland SE; Prause JU; Heegaard S
Surv Ophthalmol; 2015; 60(5):444-58. PubMed ID: 26003619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]